Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through lice... Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals. Mehr anzeigen
DURHAM, N.C., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of...
Potential Approval in Q3 2025 in Recurrent H3 K27M-Mutant Diffuse Glioma Submission Plan Follows Productive and Collaborative Pre-NDA Interactions with FDA Company to Host Conference Call on...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.19 | -5.52325581395 | 3.44 | 3.8 | 3.25 | 1475220 | 3.57890286 | CS |
| 4 | 0.2956 | 10.0054156512 | 2.9544 | 3.8 | 2.705 | 1696537 | 3.20751187 | CS |
| 12 | 2.3789 | 273.091493514 | 0.8711 | 3.8 | 0.8101 | 4495871 | 2.62121088 | CS |
| 26 | 2.44 | 301.234567901 | 0.81 | 3.8 | 0.75 | 2218613 | 2.44503522 | CS |
| 52 | 2.23 | 218.62745098 | 1.02 | 3.8 | 0.75 | 1283367 | 2.26523409 | CS |
| 156 | -2.72 | -45.5611390285 | 5.97 | 6.52 | 0.75 | 1547373 | 2.25702627 | CS |
| 260 | 1.11 | 51.8691588785 | 2.14 | 11.5696 | 0.75 | 1243990 | 3.1876298 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
